title: An open study of mupirocin in Libyan patients with skin infections.
abstract: In an open study in Libya 48 patients suffering from skin infections, usually caused by staphylococci and streptococci, were treated with a new topical antibiotic, mupirocin, applied three times daily for 7 days. By day 7 of treatment 93.5% of patients were asymptomatic and were considered cured, and 100% were considered cured 1 week later. In total, 50 bacterial strains were isolated, of which, 86% were staphylococci and 14% were streptococci. Neither adverse events nor cutaneous reactions were reported. Mupirocin 2% ointment proved to be effective and safe in the treatment of primary and secondary skin infections.
authors: Department of Dermatology, Central Hospital, Tripoli, Libya.
authors: N
authors: N
authors: El Ferghani
mesh_terms: D000287:Administration, Topical; D000328:Adult; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002648:Child; D004926:Escherichia coli; D005260:Female; D006801:Humans; D008002:Libya; D008297:Male; D008826:Microbial Sensitivity Tests; D016712:Mupirocin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D009824:Ointments; D017192:Skin Diseases, Bacterial / Q000188:drug therapy*; D013203:Staphylococcal Infections / Q000188:drug therapy*; D013211:Staphylococcus aureus; D013290:Streptococcal Infections / Q000188:drug therapy*
chemical_list: D000900:Anti-Bacterial Agents; D009824:Ointments; D016712:Mupirocin